116 related articles for article (PubMed ID: 38008418)
1. The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline.
Meng Z; Li P; Yang D; Huang H; Dong H; Qin Y; Bin Y; Li R; Wang S; Chen X; Kang M
Radiother Oncol; 2024 Feb; 191():110027. PubMed ID: 38008418
[TBL] [Abstract][Full Text] [Related]
2. Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.
Zeng L; Zhang Q; Ao F; Jiang CL; Xiao Y; Xie HH; Tang YQ; Gong XC; Li JG
Auris Nasus Larynx; 2019 Jun; 46(3):457-464. PubMed ID: 30528104
[TBL] [Abstract][Full Text] [Related]
4. Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline.
Guo Q; Xiao N; Xu H; Zong J; Xiao Y; Lu T; Xu Y; Wang B; Chen B; Pan J; Lin S
Radiother Oncol; 2022 Feb; 167():239-243. PubMed ID: 34973279
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis.
Zhang F; Cheng YK; Li WF; Guo R; Chen L; Sun Y; Mao YP; Zhou GQ; Liu X; Liu LZ; Lin AH; Tang LL; Ma J
BMC Cancer; 2015 Oct; 15():709. PubMed ID: 26472233
[TBL] [Abstract][Full Text] [Related]
6. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
Ou X; Miao Y; Wang X; Ding J; He X; Hu C
Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
[TBL] [Abstract][Full Text] [Related]
7. Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma.
Chen J; Ou D; He X; Hu C
Int J Clin Oncol; 2014 Dec; 19(6):998-1004. PubMed ID: 24337503
[TBL] [Abstract][Full Text] [Related]
8. Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study.
Li M; Huang XG; Yang ZN; Lu JY; Zhan YZ; Xie WJ; Zhou DJ; Wang L; Zhu DX; Lin ZX
Br J Radiol; 2016 Sep; 89(1065):20150621. PubMed ID: 27376590
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
Fatima K; Andleeb A; Sofi MA; Rasool MT; Fir A; Nasreen S; Dar NA
J Cancer Res Ther; 2022; 18(1):133-139. PubMed ID: 35381774
[TBL] [Abstract][Full Text] [Related]
10. Level Ib CTV delineation in nasopharyngeal carcinoma based on lymph node distribution and topographic anatomy.
Zhao Y; Liao X; Wang Y; Lan W; Ren J; Yang N; Li C; Lang J; Zhang S
Radiother Oncol; 2022 Jul; 172():10-17. PubMed ID: 35500787
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
[TBL] [Abstract][Full Text] [Related]
12. Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.
Lin F; Qiu Z; Xie D; Zhou X; Wang L; Wu Z; Cheng W; Lyu S; Su Y; Tao Y
Cancer Med; 2023 Nov; 12(21):20511-20520. PubMed ID: 37881136
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
Liang SB; Zhang N; Chen DM; Yang XL; Chen BH; Zhao H; Lu RL; Chen Y; Fu LW
Radiother Oncol; 2019 Mar; 132():223-229. PubMed ID: 30366725
[TBL] [Abstract][Full Text] [Related]
14. Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Xiao XT; Wu YS; Chen YP; Liu X; Guo R; Tang LL; Ma J; Li WF
Cancer Med; 2023 Jan; 12(2):1399-1408. PubMed ID: 35822664
[TBL] [Abstract][Full Text] [Related]
15. High-risk factors of parotid lymph node metastasis in nasopharyngeal carcinoma: a case-control study.
Wang HZ; Cao CN; Luo JW; Yi JL; Huang XD; Zhang SP; Wang K; Qu Y; Xiao JP; Li SY; Gao L; Xu GZ
Radiat Oncol; 2016 Sep; 11(1):113. PubMed ID: 27586641
[TBL] [Abstract][Full Text] [Related]
16. The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement.
Tang LL; Tang XR; Li WF; Chen L; Tian L; Lin AH; Sun Y; Ma J
Oral Oncol; 2017 Jun; 69():68-73. PubMed ID: 28559023
[TBL] [Abstract][Full Text] [Related]
17. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
18. Analysis of rare periparotid recurrence after parotid gland-sparing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Xu Y; Zhang M; Yue Q; Zong J; Lin J; Sun R; Qiu S; Lin S; Pan J
Cancer Radiother; 2016 Jul; 20(5):377-83. PubMed ID: 27372558
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Tang LL; Guo R; Zhou G; Sun Y; Liu LZ; Lin AH; Mai H; Shao J; Li L; Ma J
PLoS One; 2014; 9(10):e108375. PubMed ID: 25302611
[TBL] [Abstract][Full Text] [Related]
20. Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma.
Lin C; Lu N; Liang JL; Guo J; Gu LW; Sun R; Guo L; Yang Q
Radiother Oncol; 2023 Sep; 186():109802. PubMed ID: 37423477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
